Strides Shashun is set to acquire the brand PediaCare from Moberg Pharma for a total consideration of $5 million along with the current inventory. PediaCare originated from an acquisition in July 2016 (New Skin®, Fiber Choice® and PediaCare®, three well-established Over-The-Counter brands in the U.S. from Prestige Brands)
Peter Wolpert, CEO Moberg Pharma said:
We are pleased with the agreement with Strides which enables us to further focus on our strategic assets and M&A activities. We hope to close the transaction within the next four weeks
PediaCare has a strong equity amongst moms based on highly effective products for children, primarily within cough cold and analgesics segments with annual sales of US $6 million. With this acquisition, PediaCare will form an important part of Strides expanding its consumer healthcare portfolio along with a strong brand name.
Disclosure: We have recommended the stock as part of our portfolio. Please assume we are biased
Strides Acquires PediaCare®From Moberg Pharma For US $5 Million
Like our content? Join Capitalmind Premium.
- Equity, fixed income, macro and personal finance research
- Model equity and fixed-income portfolios
- Exclusive apps, tutorials, and member community
Subscribe Now
Or start with a free-trial
Already a subscriber?
Login Now
Related Posts
Zaggle: Smarter Spend Management for Businesses
Zaggle is an innovative fintech SaaS company specializing in expense management, transforming how businesses streamline payments and manage vendor relations. ...
Cracking the Patent Code: Natco’s Winning Formula
Natco Pharma, a leader in APIs and niche generics, faces growth challenges post-Revlimid exclusivity in FY26, with semaglutide offering long-term ...
TARIL: The Pickaxe and Shovel Play in India’s Energy Transformation
TARIL is one of the leading transformer manufacturers in India, and with the country’s growing power demand, the company is well-positioned to play a crucial ...